ARCHIVES

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Roswell Park, Karmanos Read The Cancer Letter Interactive.

December 1, 2000

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

Blacks At 11% Greater Cancer Risk, 27% Higher Mortality, NCI Tell President’s Cancer Panel

March 10, 1989

ACS Reorganization Plans, Policy Changes Discussed By Board

November 29, 1991

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010

Bill Clinton Endorses NBCC’s 2020 Goal

January 14, 2011